• MOU to undertake joint venture in Cyprus port operations
• Set to enter upstream business by operating oil platform
• Gaining eligibility to bid for Ghanaian government contracts

A recent announcement (http://dtn.fm/GtI6w), which also appeared in the Greek media, shows that Petrogress, Inc. (OTC: PGAS) is doubling down in Cyprus. Through subsidiary Petrogress Int’l, LLC (“PIL”), the company has entered into a Memorandum of Understanding (MOU) with EDT Agency Services, Ltd., under which the two companies intend to combine operations at the Port of Limassol. The collaboration also extends to future developments at Vassiliko Energy Port, where the Cyprus Port Authority has announced plans for the construction of a $300 million industrial and energy harbor. The MOU calls for a 50/50 partnership between EDT and PIL, operating under PIL’s PG Cypyard & Offshore Terminal Services unit. The joint venture will provide support services to supply vessels and offshore exploration and production platforms and will help PGAS serve the E&P needs of major international oil companies in the Cyprus Exclusive Economic Zone (EEZ). The partnership is expected to not only boost PGAS’s revenues, but the company’s profile in Limassol and Vassiliko.

EDT provides services to oil and gas exploration and production companies worldwide, and it operates its fleet of specialized support vessels from facilities in Cyprus and Egypt. In 2013, the company established facilities at Limassol to support Houston, Texas-based Noble Energy, Inc.’s Aphrodite and Leviathan Field operations in the Cyprus Exclusive Economic Zone. Its facilities now include a mud plant, heliport services and shore base support for vessels conducting survey, diving, salvage and ROV operations in the Cyprus EEZ and Eastern Mediterranean.

In addition to these developments, Petrogress, Inc. is expanding its footprint in the oil and gas business with ambitious plans in Ghana. Late last year, the company announced that it had acquired 90 percent of the shares of Petrogres Africa Co., Ltd. (“PAF”) through PIL (http://dtn.fm/uUf1y). The remaining 10 percent is privately held by Ghanaian investors. This acquisition creates a wealth of opportunity for PGAS, since, through PAF, the company will be eligible to bid on local Ghanaian government contracts. The PAF deal also goes some way toward turning Petrogress into a vertically integrated petroleum company. PGAS is already heavily involved in the midstream sector. The company, founded in 2009, transports petroleum products with a fleet of tankers based at the historic Port of Piraeus, Greece. It also internationally markets crude oil, distillates and refined products, and it operates service and shipping facilities at the Port of Limassol in Cyprus and the Port of Tema, Greater Accra, in Ghana.

PAF’s value stems from its ability, through Ghanaian government authority, to locally market oil products and conduct shipping business from the Port of Tema. Having access to port facilities in Tema will provide a service and operations hub for PGAS’s tankers currently involved in Nigerian oil trading and transport. The port will also serve as a secondary hub for repair, supply and transport ship operators servicing Ghana’s Tano Basin offshore oil fields in the Gulf of Guinea. Moreover, PAF expects to bid for operating contracts on the currently shut-in APG-1 production platform in the Saltpond Oil Field, which is located in shallow waters approximately eight miles offshore and 65 miles west of Accra. A shut-in platform is one whose output capacity has been set lower than is possible, perhaps for safety reasons.

The project is owned by the Ghana National Oil Company, which is expected to let out its operation by the end of 2017. Preliminary bid terms will require the successful applicant to make repairs on the production platform and work over the six existing wells to boost production from current levels of 300-500 barrels per day (bpd) and will also grant access for exploration and production (E&P) development on up to 10 additional offshore blocks. Current reserve estimates for Saltpond range down to 4.2 million barrels of oil and 20 billion cubic feet of gas recoverable. Unproven reserves on the studied portions of the additional blocks, however, are as high as 44 billion barrels of oil equivalent.

The APG-1 platform, nicknamed “Mr. Louie”, has an interesting history. Dating from the late 1950s, it became the first self-elevating drilling barge classed by the American Bureau of Shipping. It has been employed in the Gulf of Mexico and in the North Sea and has been in West Africa since the late 1970s. After drilling six appraisal wells at the Saltpond Oil Field in offshore Ghana, Mr. Louie was converted into an oil platform at Saltpond in 1978 and renamed, rather more impersonally, as APG-1.

PGAS is also actively seeking opportunities in operating and developing natural gas production and transmission facilities along with LNG processing in the U.S., as well as refinery operations in north and West Africa, and the transport and sales of LNG in Europe.

For more information, visit the company’s website at www.PetrogressInc.com

Let us hear your thoughts: Petrogress, Inc. Message Board

• Warren Wang, CEO of CIIX, said in a podcast interview that investors in China and the Chinese-speaking community in the U.S. and Canada want to learn more about bitcoin, cryptocurrencies
• CIIX doubles down on commitment to its bitcoin division, adding a bitcoin ATM in its California headquarters and broadcasting a daily video from the NYSE called ‘Bitcoin Multimillionaire’
• Company’s goal in FY2018 is profit, lower costs and a greater than 100 percent YOY sales increase

ChineseInvestors.com, Inc. (OTCQB: CIIX) CEO Warren Wang remains bullish on the future of bitcoin and other cryptocurrencies, and he recently said in a podcast interview that the Chinese-speaking community worldwide is eager to learn more about buying and managing digital currencies. Despite China’s ban on trading cryptocurrencies on a regulated exchange, he noted, many Chinese investors are buying and selling them on unregulated offline platforms.

In an interview with the Bad Crypto Podcast (http://dtn.fm/0yIgv), Wang explained that the Chinese investor is an important target for cryptocurrency entrepreneurs. “The Chinese investor is an advocate of gambling,” he explained. “Most today trade bitcoin and other cryptocurrencies on the offline market. The Chinese-speaking people within China and also in North America — the U.S. and Canada — are excited about bitcoin.”

CIIX recently hosted and installed a Bitcoin ATM in the lobby of its San Gabriel, California, headquarters (http://dtn.fm/4YznC). Wang called it the first ever by a Chinese company in the U.S. The company also recently attended a Toronto cryptocurrency roadshow and educational seminar on how to buy, sell and manage these coins, he noted in the interview. CIIX has doubled down on its commitment to bitcoin. It produces a daily video from the NYSE called ‘Bitcoin Multimillionaire’ focused on news of the currency (http://dtn.fm/XdX7l).

The company addresses Chinese-speaking audiences worldwide on the subject of investing in bitcoin and other cryptocurrencies, and now, with the ATM, it is actively involved in their trade. Wang has set the goals for CIIX in FY2018 as profitability, lower costs and greater than 100 percent year-over-year revenue growth (http://dtn.fm/fVro3).

Wang said that despite the lack of a regulated Chinese exchange to trade cryptocurrencies and the Chinese government’s ”badmouthing” of bitcoin though its official TV media outlet, there is a great desire by the Chinese-speaking people within China and North America to buy, sell and trade bitcoin.

“Real estate is very expensive and so are labor and rents in China,” he said. “Investors have a high savings rate. They now would like to make bitcoin and other cryptocurrencies part of their assets. They are trading offline on platforms of decentralized exchanges to do so.”

He advised entrepreneurs within the industry to be patient while the Chinese investment community learns about issues like the digital wallets used for buying, selling and managing bitcoin. “The average Chinese investor may have up to $5,000 to invest in these currencies,” he said. “But be patient.”

Wang said that, in the future, China may organize a regulated market for the trading of cryptocurrencies in order to keep monies involved in that trading within China. “But, until now, this has not happened,” he concluded.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• A possible larger role for leading drug manufacturers, and the resulting opioid epidemic, is met with increased public and government demands for alternative therapies
• The Skinvisible and Quoin merger, with expected completion in 2018, will create an enterprise positioned to disrupt the $6 billion U.S. opioid market by producing and delivering non-opioid alternatives for pain management
• Quoin’s QRX001 is slated to provide alternative and effective pain management in the post-surgical setting, where 50 percent of opioid addictions start

A recent article by the Washington Post (http://dtn.fm/cGzr2) addressed the opioid crisis, suggesting a larger role by leading pharmaceutical drug manufacturers than originally thought. The story alludes to the possibility that “drug manufacturers and distributors turned a willfully blind eye toward illegal drug trafficking.” In the midst of this, there is an opioid epidemic that has been deemed a national health emergency that results in 90 deaths per day (http://dtn.fm/JwiX6) and is growing exponentially, according to the Centers for Disease Control and Prevention.

There are increased incentives and growing public and FDA/government demands to address the crisis. Innovators vying to meet critical needs and to combat the opioid issue with alternative, non-addictive and effective products include Skinvisible, Inc. (OTCQB: SKVI) and Quoin Pharmaceuticals Limited. As announced earlier this month, the two companies have entered a Letter of Intent for a proposed merger, with expected completion in early 2018, that will result in a new entity, Quoin Pharmaceuticals Inc. Upon completion of this merger, the new company (combining Quoin’s strengths of pharmaceutical development and Skinvisible’s innovative technologies that enhance delivery and product performance) has tremendous potential to address the significant needs of the pain management market.

One of the main areas of Quoin’s focus is to disrupt the opioid market (currently estimated at $6 billion annually in the U.S. alone) and produce and deliver to market non-opioid products that serve as effective and viable alternatives for the immense pain management market. This focus will include all areas of pain management, including critical needs in the post-surgical setting. At least 50 million U.S. surgeries require the use of post-operative pain management pharmaceuticals annually, and it is in the post-surgical setting that about 50 percent of opioid addictions begin.

To address the critical demands for effective alternatives to opioids, Quoin will launch one of its first lead products, QRX001, for effective treatment of post-surgical pain. The product, a transdermal NMDA receptor antagonist, delivers up to 72 hours of effective post-surgical pain relief. With the aim of providing alternatives to opioids as well as opiates, numerous clinical studies on QRX001 have shown that sub-anesthetic doses have resulted in a marked 24-hour reduction in PCA morphine consumption. In addition, clinical tests of the NMDA receptor antagonist generated superior results to any single existing product or combination and resulted in mild or absent adverse events, reduced post-surgical nausea and vomiting and reduced pain intensity.

With completion of the merger of Skinvisible and Quoin expected in early 2018, the synergies of the merged technologies, expertise and proven track records poise the new Quoin Pharmaceuticals with tremendous potential to address the needs of the immense pain market and tackle the opioid epidemic head-on.

For more information, visit the company’s website at www.Skinvisible.com

Let us hear your thoughts: Skinvisible, Inc. Message Board

• The World Health Organization (WHO) announced that “the cannabis compound CBD (Cannabidiol) should not be internationally scheduled as a controlled substance” (www.WHO.int)
• WHO has issued preliminary findings indicating that cannabidiol (CBD) shows “no indications of abuse or dependence potential” and “a good safety profile”
• MCOA is committed to the development of high quality CBD-based products

The World Health Organization (“WHO”) officially recommended on December 14, 2017, that the chemical compound cannabidiol (CBD) no longer be internationally scheduled as a controlled substance. WHO has issued a preliminary report that found CBD to be non-addictive and generally safe. The CBD pre-review report (http://dtn.fm/Vqq2e), as issued by the agency, states, “In humans, CBD exhibits no effects indicative of any abuse or dependence potential.” The report further indicates that, “CBD is generally well tolerated and with a good safety profile. Reported adverse effects may be as a result of drug-drug interactions between CBD and patients’ existing medications.”

The wholly-owned subsidiary of Marijuana Company of America Inc. (OTC: MCOA), hempSMART™, Inc. is an affiliate marketing company that develops and brings to market hemp-derived cannabinoid-based formulations that are combined with other natural botanicals to create high quality wellness products. HempSMART’s products are now available on the company’s website, www.hempSMART.com. They include hempSMART™ Brain (http://dtn.fm/vmuZ4), created as a nootropic product; hempSMART™ Full Spectrum Drops (http://dtn.fm/FU9ue), with more bioavailability; and the newly-released hempSMART™ Pain Capsules (http://dtn.fm/fFx1l).

In a news release, Paula Vetter, a member of hempSMART’s product development team, stated, “HempSMART demonstrated its commitment to formulating a safe and synergistic natural personal care product. The hempSMART Pain formula harnesses the natural power of premium CBD, CBG and active terpenes derived from industrial hemp, combined with complimentary botanicals. Our team is focused on the development of premium personal care products for our customers.”

About hempSMART™ Pain

hempSMART™ Pain Capsules are formulated with 10mg of full dpectrum, non-psychoactive cannabidiol (CBD) per serving, derived from industrial hemp as the core ingredient, which, along with a proprietary blend of other natural ingredients, delivers an all-natural formulation for the temporary relief of minor pain associated with physical activity.

Disclaimer:

• These statements have not been evaluated by the Food and Drug Administration
• This product is not intended to treat, cure, or prevent any disease

For more information, visit the company’s websites at www.MarijuanaCompanyofAmerica.com and
www.hempSMART.com

Let us hear your thoughts: Marijuana Company of America, Inc. Message Board

• Global app revenue approaching $77 billion
• AppSwarm incubates and accelerates emerging talent in crowded market
• Company building on gaming bedrock, adding business resources and cannabis industry networks

In a crowded mobile app market where large global companies dominate the landscape, AppSwarm, Inc. (OTC: SWRM) is working to befriend smaller developers and creative thinkers who hope to elbow their way in and find an audience. The entrepreneur-incubating company has the expertise to identify promising developers who may need some assistance in getting their products to a solid revenue-building stage, as well as the resources needed to help those developers analyze the marketplace, manage the budget and establish direct sales and marketing networks.

Industry analysts expect the mobile app economy to reach a valuation of $77 billion during the coming year (http://dtn.fm/5oAUc), driven largely by the mounting ubiquity of smartphones around the world, together with the growing geographical penetration of 3G and 4G networks and numerous connectivity options such as Bluetooth and Wi-Fi (http://dtn.fm/q1YsS).

AppSwarm tests the emerging apps’ potential for user engagement and retention, capacity to gain viral traction and readiness to monetize their standout features. Many developers launch their products without a ready strategy for gaining users or a realistic model for driving revenue, and they often end up trying to manage the day-to-day funding realities post-launch. AppSwarm’s specialty is in helping to bridge the gap between understanding the apps’ strengths and the audiences using them.

The company’s bedrock foundation is centered in mobile gaming offerings, which fuel a multi-billion dollar industry with a compound annual growth rate of some 31 percent, although AppSwarm has additional revenue streams focused on casino- and movie-themed applications, technical expertise contracts and business utility apps. One example of a business utility app under its banner is a scanner for PDF documents.

The company partners with developers through joint ventures, royalty agreements, marketing partnerships and outright acquisitions. In November, AppSwarm announced that it had finalized discussions with mobile technology developer SinglePoint, Inc. (OTC: SING) to begin producing apps that boost the growing cannabis industry, including a service-based platform for the business-to-business and business-to-consumer markets that is expected to be completed by January 2018. The first app will be a blockchain and bitcoin payment technology marketed under SinglePoint’s SingleSeed subsidiary, and AppSwarm will be responsible for the technical support and application development.

The app is expected to be available in all states where the cannabis industry is legal and the product is feasible, according to the company. The venture calls for an even-split revenue share on all products to be deployed, and AppSwarm expects to report revenues of $6 million to $7 million within the coming year (http://dtn.fm/eV9CL).

During the summer, the company announced its acquisition of Russian development company Shooterboy Entertainment’s Komandir game, which is available for download from the Apple App Store and Google Play. Komandir marks AppSwarm’s foray into virtual reality, a gaming experience that has gained popularity in recent years and is predicted to reach several billion dollars in global revenues within the next four years, with more than $8 billion going toward location-based virtual reality entertainment alone, according to industry analyst Greenlight Insights (http://dtn.fm/1eFW4).

For more information, visit the company’s website at www.App-Swarm.com

Let us hear your thoughts: AppSwarm, Inc. Message Board

• Electric vehicle production increasing demand for lithium
• Chinese firms buying lithium companies
• Chinese investment in Canadian lithium set to grow

China is in the market for lithium, according to the China Economic Review (http://dtn.fm/Spf38). Chinese firms, it says, “Have been on a buying spree for lithium… companies over the past year, signing agreements for future supply of the metals. The string of deals come [sic] as auto companies have announced ambitious plans for electric vehicles in the country.” Recently, the Middle Kingdom overtook the U.S. as the country with the largest number of electric vehicles (EVs) on the road. Already with a strong presence in South America, Chinese buyers appear to be looking to the north, snapping up producers in Canada, home to Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF). This junior exploration company, based in Vancouver, is out to acquire brownfield, lithium-rich properties in the U.S. It is hoping to unlock value from overlooked U.S. lithium assets by applying both conventional and modern processing technologies. With a brownfield flagship property at Bristol Lake in the Mojave Desert, chances are high that some Chinese buyer may stop and shop.

“China has emerged as a leader in both the supply of—and demand for—electric vehicles,” a McKinsey report proclaims (http://dtn.fm/rb4vK). In 2016, Chinese manufacturers produced approximately 375,000 EVs, which accounted for 43 percent of global production. Suppliers of the lithium-ion batteries that power these vehicles are fast catching up. Chinese players now account for about 25 percent of global sales. Earlier in December 2017, Private Capital Journal reported the acquisition of Canadian producer Lithium X Energy Corp. (TSX.V: LIX) (OTCQX: LIXXF) for about $257 million by a Chinese partnership (http://dtn.fm/JDe5d). One of those partners also purchased a 20 percent stake in London-listed Bacanora Minerals.

China, which has the world’s largest auto market, is undoubtedly in pole position in the EV race. The Chinese government, seeking to cap carbon emissions, plans to phase out vehicles using gasoline and diesel by 2030, after which time only EVs will be sold. Climbing production of EVs is driving up demand for lithium. Battery-grade lithium has been trading at $20,000 a ton on the Chinese spot market, according to Fortune (http://dtn.fm/6iOym). With prices that lofty, Standard Lithium is stepping up its efforts to get the metal out of the ground. Its first project in San Bernardino County, California, at the Bristol Dry Lake has already started to show signs of promise. This past May, Standard Lithium signed an option agreement to conduct lithium exploration and project development under long-standing mineral claims and permits on the Bristol Dry Lake playa held by National Chloride Corporation of America. Test results from a new geophysical survey of the 35,000-acre Bristol Lake site indicate that high concentrations of lithium-bearing brines are present throughout the company’s mineral lease agreement claims.

Standard Lithium announced this past October that (http://dtn.fm/v8W8B) it had entered into a Memorandum of Understanding with TETRA Technologies, Inc., (NYSE: TTI) to secure access to operating and permitted land of approximately 12,100 acres in Bristol Dry Lake and up to 11,840 acres in the adjacent Cadiz Dry Lake of California’s Mojave Desert. With the recent signing of the MOU with TETRA and the option agreement with National Chloride, the actual combined project area in California now covers over 45,000 acres of the two playa. As a result of working with existing operators, a lot of the required infrastructure is already in place. The property, situated approximately 200 kilometers from Las Vegas and 330 kilometers east of the port of Los Angeles, has electric power and water and is crossed in the northwest by a major paved road (Route 66). There is also a Burlington Northern Santa Fe railroad adjacent to the site, with a purpose-built siding and loading spur-line.

Standard Lithium is also exploring for lithium in the Smackover Formation, which extends through Texas, Arkansas and Louisiana. The formation has produced billions of barrels of brines over the last 80 years from an extensive and extremely well-characterized aquifer.

With demand for lithium continuing to climb, Standard Lithium may soon be hearing a knock on the door as Chinese brokers come calling.

For more information, visit the company’s website at www.StandardLithium.com

• DehydraTECH™ is the company’s newly U.S.-patented disruptive drug delivery platform; LXRP CEO Chris Bunka says company is working on more applications for its technology in the treatment of Alzheimer’s disease, Parkinson’s disease, opioid addiction and more
• LXRP has a portfolio of patents issued in both the U.S. and Australia, plus 19 patent applications filed in the U.S. (and internationally using the Patent Cooperation Treaty), as well as national filings in 44 countries
• Company has diverse revenue streams, including out-licensing its technology to third parties with fees ranging from five to 10 percent of gross sales, as well as sales of its hemp oil cannabidiol (CBD) products, ranging from branded protein energy bars to premium teas

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka said in an audio interview with the Uptick Newswire Podcast (http://dtn.fm/e1KPR) that the company was not only surprised by how quickly it received its patent for DehydraTECH™; it was also surprised by the broadness of the patent awarded for its utilization in other sectors, which it had expected in 2018 and 2019. The company believes that the new patent has locked up the intellectual property (IP) for its next-generation drug delivery system.

“I probably think the company is more undervalued today than it was in the past,” Bunka stated in the interview. “It is potentially world-changing. The potential could deliver aspirin or Ibuprofen better than anyone else. That’s very profound.”

LXRP is a food bioscience company based in Kelowna, British Columbia, Canada, that is a technology disruptor for edible CBD. It markets a high absorption hemp oil formula, protein energy bars, exotic teas and high absorption hemp oil capsules to help the human body absorb CBD. Through potential partnerships, LXRP is now working on applying its technology to improving ingestion of several new products, such as beer, candies, cookies, capsules and pills. It owns international patent rights and has pending patents for its technology changing the way cannabinoids enter the body. Its technology provides increases in intestinal absorption rates, lower dosage size, more rapid delivery to the bloodstream and important taste-masking benefits.

Bunka also said the market does not completely understand the breadth and importance of the patent LXRP received, which also provided patent protection for potential treatment of Alzheimer’s disease, Parkinson’s disease, heart disease, opioid addition and more.

In summary, Bunka said, “The best is absolutely still to come in 2018, and I think it is going to make 2017 look boring in comparison.”

For more information, visit the company’s website at www.LexariaBioscience.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board

• If Visa and MasterCard (or others) choose to participate in the marijuana industry in the future, REFG plans to offer quick, full spectrum payment processing
• REFG’s StateSourced payment gateway is Financial Crimes Enforcement Network (FinCEN) compliant
• Medical marijuana sales will grow to $13.3 billion by 2020, and adult recreational marijuana sales are expected to reach $11.2 billion by 2020, according to Forbes

Medical Cannabis Payment Solutions (OTC: REFG) is ready for the future with a seamless transition in the event that Visa or MasterCard (or others) choose to participate in the marijuana industry. In the event of a transition, full spectrum payment processing would be readily available.

REFG provides dispensaries and related businesses with a proprietary merchant processing system designed to serve the needs of state-legalized cannabis markets. The company offers exclusive and proprietary card processing services not otherwise available through most financial institutions. The goal is to offer simple, compliant and secure payment solutions. These solutions apply to the entire cannabis industry — not just medical marijuana retailers. A growing number of marijuana dispensaries and other businesses elect not to participate in a cash-only transaction environment.

REFG is a first-tier merchant processing cannabis industry pioneer. It offers a state-of-the-art system that tracks sales and tax collection. The mission of REFG is to provide end-to-end management, across multiple management systems, to solve the fragmentation problem of medicinal marijuana operations by identifying tools that are important to them.

Offering another processing feature, the company recently announced its partnership agreement with First Bitcoin Capital Corporation (OTC: BITCF) (http://dtn.fm/8xTq6). The agreement will enable marijuana facilities and their consumer clients to conduct payment processing with StateSourced debit cards, in addition to prominent cryptocurrencies such as $Weed and bitcoin. The additional option is available to both dispensaries and consumers, per company reports.

Forbes reports that sales of medical marijuana will reach $13.3 billion by 2020, and adult recreational volume is expected to hit $11.2 billion by 2020 (http://dtn.fm/j3GM5).

For more information, visit the company’s website at www.REFG.co

Let us hear your thoughts: Medical Cannabis Payment Solutions Message Board

• Neuenergy is a chewable and revolutionary energy tablet powered by blueberries and anti-oxidants with no sugar or calories
• NeutriSci International names Glen Rehman as new CEO
• Company sees new opportunities for its product in the cannabinoid field, as well as new strategic partnerships

NeutriSci International, Inc. (OTCQB: NRXCF) (TSX.V: NU) (FRANKFURT: IN9) recently announced that it has raised $499,999.95 in a non-brokered private placement (http://dtn.fm/w5XAP), with the proceeds to be used for marketing and advertising of Neuenergy®, its branded blueberry-powered energy chewable tablet (http://dtn.fm/dKJm7). Funds will also go to the company for general corporate purposes.

In addition, the company announced that previous president Glen Rehman has been named CEO.

“This latest round of investment provides us with the opportunity to move forward with strategic new partnerships, as well as our existing ones,” Rehman stated in a news release. “We have built a solid foundation and are very excited about the opportunities that lie ahead of us as we continue to grow our sales of neuenergy, and expand into new opportunities for our product in the cannabinoid industry.”

The private placement consisted of 5,555,555 units of the company at a price of $0.09 per unit. A unit consists of one common share of the company and a purchase warrant for one-half of one common share. Each full warrant entitles the holder to acquire an additional common share at a price of $0.15 per share until June 6, 2019.

Related to the private placement, the company said it paid $31,136 in cash commissions and issued 345,956 finder’s warrants. Each of those warrants entitles the holder to acquire one common share, at a price of $0.15 per share, until June 6, 2019. All securities issued in conjunction with the placement are subject to a hold period that expires on April 7, 2018.

NeutriSci International is a Vancouver-based company that specializes in the production and formulation of nutraceutical products, with its primary focus being its Neuenergy brand natural energy and focus supplement featuring the beneficial effects of blueberries.

For more information, visit the company’s website at www.NeutriSci.com

• Company has drawn more than 450 million players to its portfolio of 300+ mobile games, with player life time values (LTVs) exceeding the cost of player acquisition on certain titles
• TAPM schedules launch of three new full-featured titles in first two quarters of 2018
• By 2020, mobile gaming market is expected to account for more than half of the total games market, which hit an estimated $108.9 billion this year

Tapinator, Inc. (OTCQB: TAPM) has been successfully growing within the surging mobile games market through its introduction of both licensed and original IP across its portfolio of 300+ games, which have attracted more than 450 million players. One such license is the ROCKY™ mobile game, which the company developed in conjunction with MGM studios. Revenues are generated by consumer app store transactions and branded advertisements.

TAPM is a New York City-based company that builds mobile games for the Apple iOS, Google Play, and Amazon App Store platforms. Its team of developers and marketers uses a proprietary and profit-driven set of processes focused on gaming category, player retention and projected profitability. It is currently experimenting with both virtual and augmented reality as these newer markets begin to take hold.

The opportunities for growth within the mobile gaming market are immense, with Newzoo Research’s ‘Global Games Market Report’ projecting that mobile games will account for more than half of the total global market by 2020 (http://dtn.fm/vFM24). The total gaming market was projected to reach $108.9 billion this year, Newzoo reported. It also estimated that mobile gaming reached $36.9 billion in 2016 (http://dtn.fm/NnQ3i).

What makes TAPM unique is that it focuses on a quantitive approach to generating shareholder value, instead of beginning the game development process with an emphasis on creative alone. Ilya Nikolayev, Tapinator’s founder and CEO, said that TAPM prioritizes games with higher player retention and projected profitability, keeping an eye toward the metrics that show a game can profitably acquire new players. The company applies a pragmatic, profit-oriented strategy in order to ensure that its games are successful in attracting players, and it looks to create series of games from its most successful projects.

Additional keys to Tapinator’s success are rapid development and a commitment to constant improvement of its more successful titles. TAPM has also developed a marketing ecosystem that allows the company to cross-promote its large player base from older titles to its newer game launches. Tapinator uses this proprietary player base to acquire between 350,000 and 400,000 new player downloads daily with no spending on external marketing, Nikolayev said in an interview with Forbes (http://dtn.fm/TcAd1).

For more information, visit the company’s website at www.Tapinator.com

Let us hear your thoughts: Tapinator, Inc. Message Board